A similar mechanism may exist in EGFR-TKI resistance, where upregulated TNNC1 may promote cancer cell survival by enhancing autophagic flux, thereby conferring resistance to EGFR-TKIs such as erlotinib. Here, TNNC1 is linked to cancer.